(Q37327240)

19 August 2017

1 reference

title

Manipulation of the ubiquitin-proteasome pathway by small DNA tumor viruses (English)

1 reference

ubiquitin-proteasome system

19 August 2017

0 references

author name string

Paola Blanchette

series ordinal

1

1 reference

PubMed ID

19013629

19 August 2017

Philip E Branton

series ordinal

2

1 reference

PubMed ID

19013629

19 August 2017

language of work or name

English

0 references

publication date

14 November 2008

1 reference

19 August 2017

1 reference

19 August 2017

384

1 reference

19 August 2017

2

1 reference

19 August 2017

317-323

1 reference

Cul7/p185/p193 binding to simian virus 40 large T antigen has a role in cellular transformation

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The epidemiology of human papillomavirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

High-risk but not low-risk HPV E2 proteins bind to the APC activators Cdh1 and Cdc20 and cause genomic instability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The HECT family of E3 ubiquitin ligases: multiple players in cancer development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Both BC-box motifs of adenovirus protein E4orf6 are required to efficiently assemble an E3 ligase complex that degrades p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Cullin-RING ubiquitin ligases: global regulation and activation cycles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Transactivation of the p53 oncogene by E1a gene products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

A chimeric protein containing the N terminus of the adeno-associated virus Rep protein recognizes its target site in an in vivo assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The adenovirus E4orf6 E3 ubiquitin ligase complex assembles in a novel fashion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

A population-based study of squamous cell vaginal cancer: HPV and cofactors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Inhibition of transcription elongation by the VHL tumor suppressor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Human papillomavirus type 18 E6 protein binds the cellular PDZ protein TIP-2/GIPC, which is involved in transforming growth factor beta signaling and triggers its degradation by the proteasome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Expression of human papillomavirus 16 E2 protein in Schizosaccharomyces pombe delays the initiation of mitosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

A causal role for human papillomavirus in head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Subcellular localization and ubiquitin-conjugating enzyme (E2) interactions of mammalian HECT family ubiquitin protein ligases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Systematic analysis and nomenclature of mammalian F-box proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Degradation of tyrosine phosphatase PTPN3 (PTPH1) by association with oncogenic human papillomavirus E6 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

SOCS1 [corrected] inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Simian virus 40 large T antigen's association with the CUL7 SCF complex contributes to cellular transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Adenovirus E4orf4 protein induces PP2A-dependent growth arrest in Saccharomyces cerevisiae and interacts with the anaphase-promoting complex/cyclosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Investigation of adenovirus occurrence in pediatric tumor entities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

SEL-10 interacts with presenilin 1, facilitates its ubiquitination, and alters A-beta peptide production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

USP11 stabilizes HPV-16E7 and further modulates the E7 biological activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Adenovirus E4orf6 assembles with Cullin5-ElonginB-ElonginC E3 ubiquitin ligase through an HIV/SIV Vif-like BC-box to regulate p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Regulation of bovine papillomavirus replicative helicase e1 by the ubiquitin-proteasome pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Induction of p53-independent apoptosis by the adenovirus E4orf4 protein requires binding to the Balpha subunit of protein phosphatase 2A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Bovine papillomavirus replicative helicase E1 is a target of the ubiquitin ligase APC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The Drosophila F box protein archipelago regulates dMyc protein levels in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Oncogenic potential of the adenovirus E4orf6 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

E4Orf6-E1B-55k-dependent degradation of de novo-generated adeno-associated virus type 5 Rep52 and capsid proteins employs a cullin 5-containing E3 ligase complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Cloning of human ubiquitin-conjugating enzymes UbcH6 and UbcH7 (E2-F1) and characterization of their interaction with E6-AP and RSP5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Is there a role for SV40 in human cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Identification of three functions of the adenovirus e4orf6 protein that mediate p53 degradation by the E4orf6-E1B55K complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Toxicity of human adenovirus E4orf4 protein in Saccharomyces cerevisiae results from interactions with the Cdc55 regulatory B subunit of PP2A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Distinct requirements of adenovirus E1b55K protein for degradation of cellular substrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Structure and transcription of human papillomavirus sequences in cervical carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Human papillomavirus (HPV) type 18 E7 protein is a short-lived steroid-inducible phosphoprotein in HPV-transformed cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Transformation induced by simian virus 40 in human renal cell cultures. I. Morphology and growth characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Complete reconstitution of conjugation and subsequent degradation of the tumor suppressor protein p53 by purified components of the ubiquitin proteolytic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Involvement of nuclear export in human papillomavirus type 18 E6-mediated ubiquitination and degradation of p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

PATJ, a tight junction-associated PDZ protein, is a novel degradation target of high-risk human papillomavirus E6 and the alternatively spliced isoform 18 E6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Inhibition of Bak-induced apoptosis by HPV-18 E6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Recognition of the polyubiquitin proteolytic signal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The quest for human cancer viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Heterogeneous etiology of squamous carcinoma of the vulva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Simian virus 40 large T antigen binds a novel Bcl-2 homology domain 3-containing proapoptosis protein in the cytoplasm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The SV40 large T antigen contains a decoy phosphodegron that mediates its interactions with Fbw7/hCdc4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

inferred from DOI database lookup

7 January 2021

based on heuristic

The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.10.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2008.10.005

1 reference

19 August 2017

1 reference

PubMed ID

19013629